VERASTEM INC (VSTM:NASDAQ)
$10 -0.04 (-0.3984%)
Analysed VERASTEM INC (VSTM:NASDAQ) News Sources
Verastem Oncology Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants
14-10-2026
yahoo.com
Verastem Cancer Drug Shows Responses in Pancreatic, Lung, and Colorectal Cancers
14-10-2026
yahoo.com
Verastem Has Positive Early Cancer Data And $250M In New Funding: What VSTM Investors Need To Know
14-10-2026
stocktwits.com
Verastem's KRAS G12D Drug Posts Pancreatic Responses, Advances to Phase III
14-10-2026
marketbeat.com
Verastem Gets a New CEO, $250M, and a Shot at Another Cancer Drug
14-10-2026
yahoo.com
Verastem’s KRAS inhibitor posts wins in mPDAC, mCRC and NSCLC
15-10-2026
clinicaltrialsarena.com
Verastem's G12D Drug Shows Promise in Pancreatic Cancer, Shares Undervalued, RBC Says
15-10-2026
yahoo.com
Verastem (VSTM) Shares Jumped On Trial Data And Funding, Is The Stock Still Cheap?
16-10-2026
yahoo.com
Verastem Oncology to Report Third Quarter 2026 Financial Results on November 5, 2026
22-10-2026
yahoo.com
What Verastem (VSTM)'s Trial Update Means For Shareholders
24-10-2026
yahoo.com
What is the current price of VERASTEM INC (VSTM:NASDAQ)?
The current price of VERASTEM INC (VSTM:NASDAQ) is $10.
VERASTEM INC (VSTM:NASDAQ) absolute price change since previous trading day?
The absolute price change of VERASTEM INC (VSTM:NASDAQ) since the previous trading day is $-0.04.
VERASTEM INC (VSTM:NASDAQ) percentage price change since previous trading day?
The percentage price change of VERASTEM INC (VSTM:NASDAQ) since the previous trading day is -0.3984%.
What is the most recent average sentiment score for VERASTEM INC (VSTM:NASDAQ)?
The most recent average sentiment score for VERASTEM INC (VSTM:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for VERASTEM INC (VSTM:NASDAQ)?
The most recent sentiment for VERASTEM INC (VSTM:NASDAQ) is .
SEC-8K** Filing Available For VERASTEM INC (VSTM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.